サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1493361

米国の皮膚科機器市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント予測、2024年～2030年

U.S. Dermatology Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic Devices, Treatment Devices), By Application, By End-use (Hospitals, Clinics), By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 70 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
米国の皮膚科機器市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント予測、2024年～2030年
出版日: 2024年05月28日
発行: Grand View Research
ページ情報: 英文 70 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国の皮膚科機器市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、米国の皮膚科機器の市場規模はｍ2030年までに127億3,000万米ドルに達すると予測され、2024年から2030年までのCAGRは12.4％で成長すると予測されています。

皮膚科機器の技術的進歩や皮膚疾患の有病率の上昇が市場成長を促進する要因の一部です。米国の皮膚科学会によると、にきびや同様の皮膚疾患は米国で年間5,000万人以上に影響を及ぼしています。

高度に開発された光治療機器、マイクロダーマブレーション機器、レーザー機器は、皮膚科の専門家が侵襲性が低く、より効果的な治療を行うのに役立っています。メーカー各社は、皮膚疾患治療のための革新的な医療機器の開発・上市に注力しています。例えば、美容医療機器の開発・製造会社であるCytrellis, Inc.は、2022年7月に同社の製品であるEllacorのFDA承認を取得しました。Ellacorは、組織のマイクロコア化を利用し、痛みが少なく、傷跡が残らないなどの利点がある皮膚治療を提供します。

皮膚疾患の早期診断と治療に関する意識の高まりが、市場の成長に寄与しています。また、経済分析局によると、米国の可処分所得は2024年1月に676億米ドル増加し、個人消費支出は439億米ドル増加しました。可処分所得の増加に伴い、スキンタイトニングやスキンリサーフェイシングなど、必須ではない皮膚治療への支出が増加し、市場成長を後押しすると予想されます。

米国形成外科学会は、世論調査に基づき、パンデミック後に75％以上の形成外科医院が業績を伸ばし、約30％の開業医が100％の業績増を報告していることを明らかにしました。Forbes Health-Ipsosの調査によると、パンデミックは個人の間で身体イメージに対する否定的な観念を増大させ、それが皮膚科サービスへの需要を高めています。

米国の皮膚科機器市場レポート・ハイライト

  • 治療機器分野は、治療機器の幅広い適用性により、2023年に79.5%の最大売上シェアで市場をリードしました。さらに、タトゥー除去などの処置に対する需要の増加は、皮膚科治療機器の需要を促進している顕著な要因です。
  • 用途別では、治療分野が2023年に最大の収益シェアを占め、予測期間中に最も速いCAGRで成長すると予測されています。これは、皮膚治療に対する需要の高まりとスキンケアに関する意識の高まりによるものです。
  • 最終用途別では、幅広い皮膚治療オプションが利用可能であることから、病院セグメントが2023年に大半のシェアを占めました。
  • クリニック分野は、待ち時間が短く、全国に多くのクリニックが存在するという利点から、予測期間中に最も速いCAGRで成長すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の皮膚科機器市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連 / 付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 米国の皮膚科機器市場分析ツール
    • 業界分析 - ポーターのファイブフォース分析
    • PESTEL分析

第4章 米国の皮膚科機器市場：製品の推定・動向分析

  • 製品市場シェア、2023年・2030年
  • セグメントダッシュボード
  • 米国の皮膚科機器市場：製品別展望
  • 市場規模・予測と動向分析、2018年～2030年

第5章 米国の皮膚科機器市場：地域推定・動向分析

  • 地域別市場シェア、2023年・2030年
  • 米国の皮膚科機器市場：地域別展望
  • 市場規模・予測と動向分析、2018年～2030年

第6章 米国の皮膚科機器市場：用途の推定・動向分析

  • 用途市場シェア、2023年・2030年
  • セグメントダッシュボード
  • 米国の皮膚科機器市場：用途別展望
  • 市場規模・予測と動向分析、2018年～2030年

第7章 米国の皮膚科機器市場：最終用途の推定・動向分析

  • 最終用途市場シェア、2023年・2030年
  • セグメントダッシュボード
  • 米国の皮膚科機器市場：最終用途別展望
  • 市場規模・予測と動向分析、2018年～2030年

第8章 競合情勢

  • 最近の動向と影響分析：主要市場参入企業別
  • 企業 / 競合の分類
  • 企業プロファイル
    • Cutera, Inc.
    • Genesis Biosystems, Inc.
    • Cytrellis, Inc.
    • Candela Medical Corporation
    • Bausch Health Companies Inc.
    • DermLite.
    • Cynosure Inc.
    • Avita Medical, Inc,
    • Skin Science Solutions, Inc.
    • Canfield Scientific, Inc.
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. dermatology devices market, by product, 2018 - 2030 (USD Million)
  • Table 3 U.S. dermatology devices market, by application, 2018 - 2030 (USD Million)
  • Table 4 U.S. dermatology devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 U.S. dermatology devices market, by region, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. dermatology devices market: Market outlook
  • Fig. 9 U.S. dermatology devices competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. dermatology devices market driver impact
  • Fig. 14 U.S. dermatology devices market restraint impact
  • Fig. 15 U.S. dermatology devices market: Product movement analysis
  • Fig. 16 U.S. dermatology devices market: Product outlook and key takeaways
  • Fig. 17 Diagnostic devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Dermatoscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Microscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Other imaging devices estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Treatment devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Light therapy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Lasers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Electrosurgical equipment estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Liposuction devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Microdermabrasion devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Cryotherapy devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. dermatology devices market: Application movement analysis
  • Fig. 30 U.S. dermatology devices market: Application outlook and key takeaways
  • Fig. 31 Diagnostics application market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Skin cancer diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Other market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Treatment application estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Hair removal market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Skin rejuvenation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Acne, psoriasis, and tattoo removal market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Wrinkle removal and skin resurfacing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Body contouring and fat removal estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Liposuction devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Cellulite reduction market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Vascular and pigmented lesion removal market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. dermatology devices market: End-use movement Analysis
  • Fig. 45 U.S. dermatology devices market: End-use outlook and key takeaways
  • Fig. 46 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 U.S. dermatology devices market: Regional movement analysis
  • Fig. 50 U.S. dermatology devices market: Regional outlook and key takeaways
  • Fig. 51 West market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-284-3

U.S. Dermatology Devices Market Growth & Trends:

The U.S. dermatology devices market size is anticipated to reach USD 12.73 billion by 2030 and is projected to grow at a CAGR of 12.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Technological advancements in dermatology devices and the rising prevalence of skin disorders are some of the factors driving the market growth. According to the American Academy of Dermatology Association, acne, and similar skin conditions affect over 50 million people in the U.S. annually.

Highly developed light therapy devices, microdermabrasion devices, and laser devices help dermatology professionals deliver less invasive and more effective treatments. Manufacturers are focusing on developing and launching innovative medical devices for treating skin conditions. For instance, Cytrellis, Inc., a developer and manufacturer of aesthetic medical devices, received its FDA approval in July 2022 for its product Ellacor, which uses tissue micro-coring to deliver skin treatments that are less painful and non-scarring, among other benefits.

Growing awareness regarding early diagnosis and treatment of skin disorders has contributed to the market growth. In addition, according to the Bureau of Economic Analysis, disposable personal income in the U.S. increased by USD 67.6 billion, and personal consumption expenditure increased by USD 43.9 billion in January 2024. As disposable income rises, expenditure on non-essential skin treatments, such as skin tightening and skin resurfacing, among others, is anticipated to increase and boost the market growth.

The American Society of Plastic Surgeons uncovered, based on a poll, that more than 75% of plastic surgery practices gained more business after the pandemic, with approximately 30% of practitioners reporting a 100% increase in business. According to a Forbes Health-Ipsos survey, the pandemic increased negative notions of body image among individuals, which has been increasing the demand for dermatology services.

U.S. Dermatology Devices Market Report Highlights:

  • The treatment devices segment led the market with the largest revenue share of 79.5% in 2023, owing to the broad applicability of treatment devices. Moreover, the increasing demand for procedures such as tattoo removal is a notable factor fueling the demand for dermatology treatment devices
  • Based on application, the treatment segment accounted the market with the largest revenue share in 2023 and is projected to grow at the fastest CAGR over the forecast period, owing to rising demand for skin treatments and growing awareness regarding skin care
  • Based on end-use, the hospitals segment held a majority share in 2023, due to the availability of a wide range of skin treatment options
  • The clinics segment is projected to grow at the fastest CAGR during the forecast period, owing to the benefit of shorter waiting periods and a large number of clinics present across the nation

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Dermatology Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Dermatology Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Dermatology Devices Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Dermatology Devices Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Diagnostic devices
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.1.1. Dermatoscope
      • 4.4.1.1.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.1.2. Microscopes
      • 4.4.1.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.1.3. Other Imaging Devices
      • 4.4.1.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.1.4. Biopsy Devices
      • 4.4.1.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Treatment devices
      • 4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.1.1. Light Therapy Devices
      • 4.4.2.1.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.1.2. Lasers
      • 4.4.2.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.1.3. Electrosurgical Equipment
      • 4.4.2.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.1.4. Liposuction Devices
      • 4.4.2.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.1.5. Microdermabrasion Devices
      • 4.4.2.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.1.6. Cryotherapy Devices
      • 4.4.2.1.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. U.S. Dermatology Devices Market: Region Estimates & Trend Analysis

  • 5.1. Regional Market Share, 2023 & 2030
  • 5.2. U.S. Dermatology Devices Market by Region Outlook
  • 5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 5.3.1. West
      • 5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Midwest
      • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Northeast
      • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.4. Southwest
      • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.5. Southeast
      • 5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Dermatology Devices Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. U.S. Dermatology Devices Market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Diagnostics Application
      • 6.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.1.1.1. Skin Cancer Diagnosis
      • 6.4.1.1.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.1.1.2. Other
      • 6.4.1.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.2. Treatment application
      • 6.4.2.1. Treatment application market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.2.1.1. Hair Removal
      • 6.4.2.1.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.2.1.2. Skin Rejuvenation
      • 6.4.2.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.2.1.3. Acne, Psoriasis, and Tattoo Removal
      • 6.4.2.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.2.1.4. Wrinkle Removal and Skin Resurfacing
      • 6.4.2.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.2.1.5. Body Contouring and Fat Removal
      • 6.4.2.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.2.1.6. Vascular and Pigmented Lesion Removal
      • 6.4.2.1.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.2.1.7. Others
      • 6.4.2.1.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. U.S. Dermatology Devices Market: End-use Estimates & Trend Analysis

  • 7.1. End-use Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. U.S. Dermatology Devices Market by End-use Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Hospitals
      • 7.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. Clinics
      • 7.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. Others
      • 7.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Company Profiles
    • 8.3.1. Cutera, Inc.
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Genesis Biosystems, Inc.
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Cytrellis, Inc.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Candela Medical Corporation
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bausch Health Companies Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. DermLite.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Cynosure Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Avita Medical, Inc,
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Skin Science Solutions, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Canfield Scientific, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives